Pharmacogenomics for precision medicine
- Submission status
- Open
Healthcare is gradually moving away from a one-size fits all approach to a greater focus on patients as individuals. Precision medicine aims to identify subpopulations of patients that will best respond to specific treatments in order to optimise care. Pharmacogenomics, the study of genome variation in drug response, is a key tool in meeting this aim.
This Collection will present recently identified genomic pathways, novel genetic biomarkers, and epigenetic signals that influence treatment outcomes for particular patient populations.
Editors
-
Mayumi Ueta
Kyoto Prefectural University of Medicine, Japan
-
Wei-Qi Wei
Vanderbilt University Medical Center (VUMC), USA
Submitting a paper for consideration
To submit your manuscript for consideration at Scientific Reports as part of this Collection, please follow the steps detailed on this page. On the first page of our online submission system, under “I’m submitting:” select the option “any other article type”. Once logged in you can submit your manuscript to a Collection by selecting “Guest Edited Collection”, under the “Choose the appropriate manuscript type” message, and clicking “Continue”. Then when filling out the manuscript information, select the "Pharmacogenomics for precision medicine" Collection from the alphabetical list on the “Springer Nature Subject Category” tab. Authors should express their interest in the Collection in their cover letter.
Accepted papers are published on a rolling basis as soon as they are ready.
In addition to papers on Pharmacogenomics for precision medicine, Scientific Reports welcomes all original research in the field of Drug discovery. To browse our latest articles in Drug discovery, click here.
